-
1
-
-
0032588487
-
PPARγ, the ultimate thrifty gene
-
Auwerx J (1999) PPARγ, the ultimate thrifty gene. Diabetologia 42:1033-1049.
-
(1999)
Diabetologia
, vol.42
, pp. 1033-1049
-
-
Auwerx, J.1
-
2
-
-
8744299422
-
Is the future bright for diabetes?
-
Bond M and Yates S (2004) Is the future bright for diabetes? South Med J 97:1027-1028.
-
(2004)
South Med J
, vol.97
, pp. 1027-1028
-
-
Bond, M.1
Yates, S.2
-
4
-
-
0033549616
-
Rapid rise in the incidence of type 2 diabetes from 1987 to 1996
-
Burke J, Williams K, and Gaskill S (1999) Rapid rise in the incidence of type 2 diabetes from 1987 to 1996. Arch Intern Med 159:1450-1460.
-
(1999)
Arch Intern Med
, vol.159
, pp. 1450-1460
-
-
Burke, J.1
Williams, K.2
Gaskill, S.3
-
5
-
-
0026572747
-
Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: A balanced overview
-
DeFronzo R (1992) Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: a balanced overview. Diabetologia 35:389-397.
-
(1992)
Diabetologia
, vol.35
, pp. 389-397
-
-
DeFronzo, R.1
-
6
-
-
2542454565
-
Be fit or be sick: Peroxisome proliferator-activated receptors are down the road
-
Desvergne B, Michalik L, and Wahli W (2004) Be fit or be sick: peroxisome proliferator-activated receptors are down the road. Mol Endocrinol 18:1321-1332.
-
(2004)
Mol Endocrinol
, vol.18
, pp. 1321-1332
-
-
Desvergne, B.1
Michalik, L.2
Wahli, W.3
-
7
-
-
0038460622
-
Thiazolidinediones in type 2 diabetes mellitus: Current clinical evidence
-
Diamant M and Heine R (2003) Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence. Drugs 63:1373-1405.
-
(2003)
Drugs
, vol.63
, pp. 1373-1405
-
-
Diamant, M.1
Heine, R.2
-
8
-
-
0032866430
-
Catechin is present as metabolites in human plasma after consumption of red wine
-
Donovan J, Bell J, Kasim-Karakas S, German J, Walzem R, Hansen R, and Waterhouse A (1999) Catechin is present as metabolites in human plasma after consumption of red wine. J Nutr 129:1662-1668.
-
(1999)
J Nutr
, vol.129
, pp. 1662-1668
-
-
Donovan, J.1
Bell, J.2
Kasim-Karakas, S.3
German, J.4
Walzem, R.5
Hansen, R.6
Waterhouse, A.7
-
9
-
-
0032456709
-
Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: Problems and prospects
-
Ferrannini E (1998) Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr Res 19:477-490.
-
(1998)
Endocr Res
, vol.19
, pp. 477-490
-
-
Ferrannini, E.1
-
10
-
-
0027447461
-
Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers
-
Keller H, Dreyer C, Medin J, Mahfoudi A, Ozato K, and Wahli W (1993) Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci USA 90:2160-2164.
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 2160-2164
-
-
Keller, H.1
Dreyer, C.2
Medin, J.3
Mahfoudi, A.4
Ozato, K.5
Wahli, W.6
-
12
-
-
0023431327
-
Comparative metabolism and excretion of resorcinol in male and female rats
-
Kim Y and Matthews H (1987) Comparative metabolism and excretion of resorcinol in male and female rats. Fundam Appl Toxicol 9:409-414.
-
(1987)
Fundam Appl Toxicol
, vol.9
, pp. 409-414
-
-
Kim, Y.1
Matthews, H.2
-
13
-
-
0024787109
-
Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs-1
-
Knihinicki R, Williams K, and Day R (1989) Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs-1. Biochem Pharmacol 38:4389-4395.
-
(1989)
Biochem Pharmacol
, vol.38
, pp. 4389-4395
-
-
Knihinicki, R.1
Williams, K.2
Day, R.3
-
14
-
-
22144477183
-
Ligands to peroxisome proliferator activated receptors as therapeutic options for metabolic syndrome
-
Liu Y and Reifel-Miller A (2005) Ligands to peroxisome proliferator activated receptors as therapeutic options for metabolic syndrome. Drug Discov Today Ther Strategies 2:165-169.
-
(2005)
Drug Discov Today Ther Strategies
, vol.2
, pp. 165-169
-
-
Liu, Y.1
Reifel-Miller, A.2
-
15
-
-
0033857387
-
Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists
-
Olefsky J (2000) Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists. J Clin Investig 106:467-472.
-
(2000)
J Clin Investig
, vol.106
, pp. 467-472
-
-
Olefsky, J.1
-
16
-
-
17744385549
-
Efficacy of LY519818, a novel non-TZD, PPARγ-dominant αγ dual agonist
-
Prince M, Spicer K, Caro J, Abu-Raddad E, Konrad R, Wang M, Negrovilar A, and Danaberg J (2004) Efficacy of LY519818, a novel non-TZD, PPARγ-dominant αγ dual agonist. Diabetes 52 (Suppl 2):A33.
-
(2004)
Diabetes
, vol.52
, Issue.SUPPL. 2
-
-
Prince, M.1
Spicer, K.2
Caro, J.3
Abu-Raddad, E.4
Konrad, R.5
Wang, M.6
Negrovilar, A.7
Danaberg, J.8
-
17
-
-
8744290951
-
Type 2 diabetes: Epidemiologic trends, evolving pathogenic concepts, and recent changes in therapeutic approach
-
Rizvi A (2004) Type 2 diabetes: epidemiologic trends, evolving pathogenic concepts, and recent changes in therapeutic approach. South Med J 97:1079-1087.
-
(2004)
South Med J
, vol.97
, pp. 1079-1087
-
-
Rizvi, A.1
-
18
-
-
0034681773
-
Thiazolidinediones: An update
-
Schoonjans K and Auwerx J (2000) Thiazolidinediones: an update. Lancet 355:1008-1010.
-
(2000)
Lancet
, vol.355
, pp. 1008-1010
-
-
Schoonjans, K.1
Auwerx, J.2
-
19
-
-
0031739467
-
Alterations of the catalytic activities of drug-metabolizing enzymes in cultures of human liver slices
-
Vandenbranden M, Wrighton S, Ekins S, Gillespie J, Binkley S, Ring B, Gadberry M, Mullins D, Strom S, and Jensen C (1998) Alterations of the catalytic activities of drug-metabolizing enzymes in cultures of human liver slices. Drug Metab Dispos 26:1063-1068.
-
(1998)
Drug Metab Dispos
, vol.26
, pp. 1063-1068
-
-
Vandenbranden, M.1
Wrighton, S.2
Ekins, S.3
Gillespie, J.4
Binkley, S.5
Ring, B.6
Gadberry, M.7
Mullins, D.8
Strom, S.9
Jensen, C.10
|